Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
unbuzzd
- Development stage
- Unknown
- Lead developer
- Quantum BioPharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
unbuzzd is a proprietary dietary supplement beverage developed to accelerate the metabolism of alcohol, reduce blood alcohol concentration (BAC), and alleviate symptoms of intoxication and hangover. The formulation consists of a blend of vitamins, minerals, and supplements designed to support liver and brain function by enhancing the activity of enzymes such as alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). Clinical trials have demonstrated that unbuzzd can significantly speed up the reduction in BAC—by over 40% compared to placebo—while improving mental alertness, reducing perceived impairment, fatigue, and hangover symptoms. The product is well-tolerated with no reported adverse side effects. Developed by Quantum BioPharma, it targets both consumer use for rapid recovery after drinking as well as potential hospital applications for acute alcohol intoxication[2][4][5][8].
- Brand names
- unbuzzd
- Other names
- unbuzzd
02
Targets
ADH (Alcohol dehydrogenase family)ALDH1A1 (Aldehyde dehydrogenase 1 family member A1)
Beyond the preview
Go deeper on unbuzzd.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on unbuzzd.